Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Kelly, YP; da, Costa, BR; Beaubien-Souligny, W; Clark, EG; Murray, PT; Nichol, A; Wald, R; Bagshaw, SM, , STandard, vs., Accelerated, initiation, of, Renal, ReplacementTherapy, in, Acute, Kidney, Injury, (STARRT-AKI), Investigators.
Factors associated with adverse haemodynamic events during the STARRT-AKI trial: a post-hoc secondary analysis.
Crit Care. 2025; 29(1): 534 Doi: 10.1186/s13054-025-05693-0 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Study Group Mitglieder der Med Uni Graz:
Eller Philipp
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
INTRODUCTION: Haemodynamic adverse events related to renal replacement therapy are a complication of all RRT modalities used in the ICU, including intermittent haemodialysis (IHD), sustained low efficiency dialysis (SLED) and continuous renal replacement therapy (CRRT). At present it is unclear which risk factors predispose to HAE and whether these contribute to adverse patient outcomes. METHODS: We performed a secondary analysis of the multinational STARRT-AKI trial to assess factors associated with the occurrence of haemodynamic adverse events (HAE) in patients receiving RRT and whether these HAE were associated with less favourable clinical outcomes. The primary analysis was a multivariable Cox proportional hazards model based on the least absolute shrinkage and selection operator (LASSO), which included time to HAE as the dependent variable. RESULTS: Factors significantly associated with an increased hazard ratio (HR) for HAE during RRT were a higher SOFA score at RRT initiation (HR 1.05; 95% 1.00-1.10), use of IHD as the initial RRT modality in comparison to CRRT (HR 1.74; 95% CI 1.28-2.37) and use of SLED as the initial RRT modality in comparison to CRRT (HR 2.73; 95% CI 1.65-4.51). In a multivariable analysis, adjusted for baseline patient characteristics and RRT initiation covariates, there was no significant association between the occurrence of a HAE during RRT and mortality, dialysis dependence, length of stay, RRT-free days, ventilator-free days or vasoactive-free days, respectively. There was, however, a significant association between multiple haemodynamic adverse events and all-cause mortality at 90 days. CONCLUSIONS: In this secondary analysis of the STARRT-AKI trial, the use of intermittent RRT modalities and higher severity of illness were associated with HAE during RRT. These events were not significantly associated with adverse clinical outcomes, apart from a significant association between multiple HAE and all-cause mortality at 90 days.
Find related publications in this database (using NLM MeSH Indexing)
Humans - administration & dosage
Male - administration & dosage
Female - administration & dosage
Aged - administration & dosage
Middle Aged - administration & dosage
Hemodynamics - physiology
Renal Replacement Therapy - adverse effects, methods
Acute Kidney Injury - therapy, physiopathology, mortality
Risk Factors - administration & dosage
Proportional Hazards Models - administration & dosage
Renal Dialysis - adverse effects

Find related publications in this database (Keywords)
Acute kidney injury
Renal replacement therapy
Haemodynamic adverse events
Hypotension
arrhythmia
Acute kidney injury
Renal replacement therapy
Haemodynamic adverse events
Hypotension
arrhythmia
© Med Uni Graz • Impressum